eLetters

243 e-Letters

published between 2003 and 2006

  • Authors' response
    Neeru Gupta MD PhD

    Dear Editor,

    We thank Dr. John Sloper for his comments regarding this clinical pathological case of advanced human glaucoma, visual field loss, and central visual system degeneration. [1] Dr. Sloper states "Gupta et al. state that both magnocellular and parvocellular cells from the lateral geniculate nucleus of a patient with glaucoma are significantly smaller than those in three control subjects." We respectf...

    Show More
  • Patching treatment and bullying
    Konstandina Koklanis

    Dear Editor,

    We read with great interest the “Bullying and eye patching” commentary by Williams and co-workers in which they report on the psychosocial implications of early versus late treatment of amblyopia.[1] In their birth cohort study, they found that early detection (screening at the age of 3 years and 1 month) and subsequent early treatment of amblyopia resulted in fewer reports of bullying victimisatio...

    Show More
  • Visual pathway changes in glaucoma
    John J Sloper

    Dear Editor,

    Gupta et al. state that both magnocellular and parvocellular cells from the lateral geniculate nucleus (LGN) of a patient with glaucoma are significantly smaller than those in three control subjects. However it would appear that the authors have used the sample sizes and standard deviation of the cell samples from each individual to make comparisons between subjects. This is statistically invalid...

    Show More
  • Effect of topical NSAID on IOP reduction by latanoprost
    Ciro Costagliola

    Dear Editor,

    We read with great interest the article by Chiba and co-workers about the possible effect on intraocular pressure (IOP) induced by non-steroidal anti-inflammatory (NSAID) ophthalmic solution in patients affected by primary open angle glaucoma (POAG) or ocular hypertension (OH) and treated with latanoprost [1].

    In 2003, Kashiwagi and Tsukahara (two co-authors of the above-mentioned Chiba et al...

    Show More
  • The social impact of visual impairment
    Geraint P Williams

    Dear Editor

    We read with interest the extended report by Hassell and colleagues [1] demonstrating the adverse effect of quality of life in mild visual impairment (<6/12) and worse. Their demonstration of the impact of Age Related Macular Degeneration (AMD) on quality of life indices is an important illustration of the difficulties experienced by the visually impaired.

    We have reported a similar exper...

    Show More
  • Bacterial co-infection in mycotic keratitis in India - a tertiary eye care centre experience
    Sujith Vengayil

    Dear Editor,

    We read with great interest the article published by Pate JC (1) in your journal and the editorial (2), regarding polymicrobial infection of cornea. Our centre is a tertiary level eye care centre in northern India and also the apex centre for eye care of the country. We, in our country come across a large number of fungal keratitis cases compared to that reported in western studies. Though the author...

    Show More
  • Topical use of cyclosporine A
    Antonio G Secchi

    Dear Editor,

    I have just finished reading the interesting paper by Daniell et al and, being one of the first authors (Secchi AG et al, AJO, 1990, 110, 137- 42) to become interested in the topical use of Cyclosporine A in "allergic" conditions concerning the ocular surface, I would like to make a few comments - based above all on a 20-year experience in the treatment of vernal keratoconjunctivitis (VKC) with topi...

    Show More
  • Re: Dietary lutein and zeaxanthin (LZ) and the risk of age related macular degeneration?
    Paul Beaumont
  • Scleral tunnel for Molteno implant insertion
    Sunil P Deokule

    Dear Editor,

    We would like to commend authors for describing a modification to surgical technique for insertion of Molteno tube implant that eliminates the need for a donor patch scleral graft.1 The purpose of this modification is laudable however we do envisage few surgical difficulties with this modification. Firstly the creation of scleral tunnel using a curved 20 gauge microvitreoretinal (MVR) blade creat...

    Show More
  • Re: Management of subretinal macular haemorrhage by direct administration of tPA
    H. K Kang

    Dear Sir,

     

    We read with great interest the report by Singh et al,1 describing the management of subretinal macular haemorrhage by vitrectomy, subretinal injection of tissue plasminogen activator (tPA) and pneumatic tamponade. Our experience with this techinque has also been positive, and this approa...

    Show More

Pages